Efficacy of green tea extract on ocular redness

Efficacy of EyeCalmin eye drop on inflammation of ocular surface

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT138903234166N1

Enrollment

Registered

2010-09-15

Start date

2009-04-04

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ocular surface irritation. Acute atopic conjunctivitis

Interventions

Intervention 1: eyecalmin 4 times a day for two weeks. Intervention 2: placebo 4 times a day for 2 weeks.

Treatment - Drugs

Placebo

eyecalmin 4 times a day for two weeks

placebo 4 times a day for 2 weeks

Eligibility

Sex/Gender

All

Age

30 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1.ocular redness 2.foriegn body sensation 3.eyestrain 4.ocular allergy. Exclusion criteria: 1.any intraocular inflammation 2.any corneal disease 3.viral or bacterial infections 4.any drug induced side effects

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Forignn body sensation, redness, irritation, eye strain. Timepoint: 2 weeks. Method of measurement: clinical exam.	—

Secondary

Measure	Time frame
Tear film stability. Timepoint: 2 weeks. Method of measurement: clinical exam.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRana Daei Sorkhabi

Tabriz universit of medacal sciences

sorkhabi_r@yahoo.com , rana@tbzmed.ac.ir+98 41 1655 1332

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026